MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurogene (NGNE) Ownership - Who owns Neurogene?
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning)... Show more
Profile
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
280.3M
P/E Ratio
N/A
Total Cash
274.52M
Projected Growth
N/A
Total Debt
12.85M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
19.23
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NGNE
Capitalization
280M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
275M
Total Cash/Share
19.23
Total Debt
12.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
273M
P/B Ratio
1.03
Cash Flow
N/A
Earnings
-4.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
18.07
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-81.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.38
Shares Held By Institutions
275M
Shares Outstanding - Current
14.3M
Total Liabilities
24.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.086
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com